Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Glycosuria: The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).
Trial | Phase | Enrollment | Study Type | Start Date | Status |
A Double-Blind, Randomized, Placebo Controlled, 2-Period Crossover Study to Evaluate the Effect of a Single Dose of JNJ-28431754 (Canagliflozin) on Gastrointestinal Glucose Absorption and Metabolism in Healthy Subjects[NCT01173549] | Phase 1 | 26 participants (Actual) | Interventional | 2010-11-30 | Completed |
A Multicentre Observational Study to Investigate the Improvement in Glucose FLuctuation of Sufficient Acarbose Therapy on Type 2 Diabetes Patient With High Blood Glucose Fluctuation[NCT03805191] | | 900 participants (Anticipated) | Observational | 2019-01-01 | Recruiting |
A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen: The 'Can Do Ramadan' Study[NCT02694263] | Phase 4 | 25 participants (Actual) | Interventional | 2016-07-31 | Completed |
Canagliflozin-Mealtime Insulin Rescue[NCT02624908] | Phase 4 | 40 participants (Anticipated) | Interventional | 2016-01-31 | Active, not recruiting |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Article | Year |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes care, 2013, Volume: 36, Issue:8
Topics: Acetaminophen; Adolescent; Adult; Blood Glucose; Canagliflozin; Cross-Over Studies; Depression, Chem | 2013 |